| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |